{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:50:50Z","timestamp":1793875850651,"version":"4.7.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jbspin.2026.106032","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T19:02:44Z","timestamp":1769713364000},"page":"106032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["High-dose chemotherapy and transplantation of autologous CD34+ selected stem cells for progressive systemic sclerosis adjusted to cardiac and lung manifestation: An open-label, non-inferiority phase 2 trial"],"prefix":"10.1016","volume":"93","author":[{"given":"Ann-Christin","family":"Pecher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Koetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Peis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhild","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lengerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wichard","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Krumm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schmalzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Wirths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8385-6861","authenticated-orcid":false,"given":"Joerg","family":"Henes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9790","key":"10.1016\/j.jbspin.2026.106032_bib0125","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.jbspin.2026.106032_bib0130","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"van Laar","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jbspin.2026.106032_bib0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jbspin.2026.106032_bib0140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3324\/haematol.2019.230128","article-title":"Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party","volume":"106","author":"Henes","year":"2021","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jbspin.2026.106032_bib0145","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2009.013458","article-title":"Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years\u2019 experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases","volume":"95","author":"Farge","year":"2010","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jbspin.2026.106032_bib0150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3899\/jrheum.110868","article-title":"Optimization of autologous stem cell transplantation for systemic sclerosis\u00a0\u2013\u00a0a single-center longterm experience in 26 patients with severe organ manifestations","volume":"39","author":"Henes","year":"2012","journal-title":"J Rheumatol"},{"issue":"SI","key":"10.1016\/j.jbspin.2026.106032_bib0155","doi-asserted-by":"crossref","first-page":"SI107","DOI":"10.1093\/rheumatology\/keac455","article-title":"Mobilization with reduced cyclophosphamide for autologous stem cell transplantation is feasible in patients with systemic sclerosis","volume":"62","author":"Pecher","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.jbspin.2026.106032_bib0160","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/rheumatology\/ket464","article-title":"Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations","volume":"53","author":"Henes","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.jbspin.2026.106032_bib0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jbspin.2026.106032_bib0170","first-page":"789","article-title":"The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales","volume":"9","author":"Fries","year":"1982","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jbspin.2026.106032_bib0175","first-page":"79","article-title":"Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument","volume":"25","author":"Silman","year":"1998","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.jbspin.2026.106032_bib0180","first-page":"144","article-title":"[Comparative evaluation of a German version of the Health Assessment Questionnaire and the Hannover Functional Capacity Questionnaire]","volume":"56","author":"Lautenschlager","year":"1997","journal-title":"Z Rheumatol"},{"issue":"1","key":"10.1016\/j.jbspin.2026.106032_bib0185","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41409-020-0978-2","article-title":"Cardiac safe hematopoietic stem cell transplantation for systemic sclerosis with poor cardiac function: a pilot safety study that decreases neutropenic interval to 5 days","volume":"56","author":"Burt","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jbspin.2026.106032_bib0190","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/bmt.2016.126","article-title":"Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?","volume":"51","author":"Oliveira","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jbspin.2026.106032_bib0195","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jbspin.2026.106032_bib0200","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13075-022-02948-x","article-title":"Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registry","volume":"24","author":"Blank","year":"2022","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.jbspin.2026.106032_bib0205","doi-asserted-by":"crossref","first-page":"e0284476","DOI":"10.1371\/journal.pone.0284476","article-title":"Systematic review and meta-analysis of anti-thymocyte globulin dosage as a component of graft-versus-host disease prophylaxis","volume":"18","author":"Zuckermann","year":"2023","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jbspin.2026.106032_bib0210","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.bmt.1703575","article-title":"Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation","volume":"29","author":"Allan","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"25","key":"10.1016\/j.jbspin.2026.106032_bib0215","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jbspin.2026.106032_bib0220","doi-asserted-by":"crossref","first-page":"e0126707","DOI":"10.1371\/journal.pone.0126707","article-title":"Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy","volume":"10","author":"Mueller","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jbspin.2026.106032_bib0225","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12968-016-0289-3","article-title":"Cardiovascular magnetic resonance patterns of biopsy proven cardiac involvement in systemic sclerosis","volume":"18","author":"Krumm","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"issue":"4","key":"10.1016\/j.jbspin.2026.106032_bib0230","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF01703240","article-title":"Cytotoxic drug-induced pneumonia and possible augmentation by G-CSF\u00a0\u2013\u00a0clinical attention","volume":"66","author":"Iki","year":"1993","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.jbspin.2026.106032_bib0235","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1097\/01.CCM.0000050453.28177.33","article-title":"Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis","volume":"31","author":"Azoulay","year":"2003","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jbspin.2026.106032_bib0240","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0954-6111(99)90080-X","article-title":"Pulmonary toxicity of chemotherapy and G\/GM-CSF: a report of five cases","volume":"93","author":"Couderc","year":"1999","journal-title":"Respir Med"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X26000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X26000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:07:31Z","timestamp":1778800051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X26000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1297319X26000011"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2026.106032","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose chemotherapy and transplantation of autologous CD34+ selected stem cells for progressive systemic sclerosis adjusted to cardiac and lung manifestation: An open-label, non-inferiority phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2026.106032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Fran\u00e7aise de Rhumatologie.","name":"copyright","label":"Copyright"}],"article-number":"106032"}}